These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15168735)

  • 1. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.
    Scharovsky OG; Binda MM; Rozados VR; Bhagat S; Cher ML; Bonfil RD
    Clin Exp Metastasis; 2004; 21(2):177-83. PubMed ID: 15168735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.
    Binda MM; Matar P; González AD; Rozados VR; Gervasoni SI; Scharovsky OG; Bonfil RD
    Int J Cancer; 2002 Jul; 100(1):14-21. PubMed ID: 12115581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
    Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
    FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin-mediated concomitant resistance in neuroblastoma.
    Streck C; Zhang Y; Zhou J; Ng CY; Davidoff A
    J Pediatr Surg; 2004 Mar; 39(3):405-11; discussion 405-11. PubMed ID: 15017561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of antiangiogenic therapies for the prevention of liver metastases.
    Mi J; Sarraf-Yazdi S; Zhang X; Cao Y; Dewhirst MW; Kontos CD; Li CY; Clary BM
    J Surg Res; 2006 Mar; 131(1):97-104. PubMed ID: 16242720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T; Ren C; Ponnazhagan S
    Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
    Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
    Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiogenesis in tumor growth and metastasis.
    Folkman J
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
    Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
    Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
    Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
    Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
    Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
    Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological effect of endostatin on transplanted human lung adenocarcinoma Calu-6 tumor in nude mice].
    Wang J; Huang C; Wei XY; Zhan ZL; Sun H; Yang Y; Li K
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):266-9. PubMed ID: 18788629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
    Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
    Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors.
    Sun X; Qiao H; Jiang H; Zhi X; Liu F; Wang J; Liu M; Dong D; Kanwar JR; Xu R; Krissansen GW
    Cancer Gene Ther; 2005 Jan; 12(1):35-45. PubMed ID: 15486558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.